Home
Conditions
Progesterone Receptor-negative Breast Cancer

Clinical trial condition

Progesterone Receptor-negative Breast Cancer

Explore clinical trials studying Progesterone Receptor-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

13 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Progesterone Receptor-negative Breast Cancer trial results

Active, not recruiting

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

NCT02315196

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +13 more
Locations: Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

NCT01805076

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations: Banner MD Anderson Cancer Center Gilbert, Arizona, United States

Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States

Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States

Enloe Medical Center Chico, California, United States

View all 179 locations

View Trial Details

Completed

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

NCT01818063

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +12 more
Locations: Walter Reed National Military Medical Center Bethesda, Maryland, United States

Thomas Jefferson University Philadelphia, Pennsylvania, United States

Reading Hospital Reading, Pennsylvania, United States

View Trial Details

Completed

Medroxyprogesterone +/- Cyclophosphamide & Methotrexate in Hormone Receptor-Negative Recurrent/Metastatic Breast Cancer

NCT00577122

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +7 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of California, San Francisco Comprehensive Cancer Center San Francisco, California, United States

Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

NCT01037790

Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Adult Central Nervous System Germ Cell Tumor, +74 more
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

F-18 16 Alpha-Fluoroestradiol-Labeled Positron Emission Tomography in Predicting Response to First-Line Hormone Therapy in Patients With Stage IV Breast Cancer

NCT00602043

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-positive Breast Cancer, +8 more
Locations: University of Washington Medical Center Seattle, Washington, United States

View Trial Details

Completed

Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer

NCT00733408

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations: Anchorage Oncology Centre Anchorage, Alaska, United States

Katmai Oncology Group Anchorage, Alaska, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Yuma Cancer Center Yuma, Arizona, United States

View all 17 locations

View Trial Details

Completed

Combination Chemotherapy and Filgrastim Before Surgery in Treating Patients With HER2-Positive Breast Cancer That Can Be Removed By Surgery

NCT00194779

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +12 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer

NCT01104259

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +14 more
Locations: Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

NCT00003199

Conditions: Breast Diseases, Breast Neoplasms, Breast Neoplasms, Male, +13 more
Locations: Fred Hutchinson Cancer Research Center/Puget Sound Oncology Consortium Seattle, Washington, United States

View Trial Details

Progesterone Receptor-negative Breast Cancer

Progesterone Receptor-negative Breast Cancer trial results

Related conditions